| Loss of acetylation at Lys16 and trimethylation at Lys20 of histone H4 is a common hallmark of human cancer MF Fraga, E Ballestar, A Villar-Garea, M Boix-Chornet, J Espada, ... Nature genetics 37 (4), 391-400, 2005 | 2367 | 2005 |
| Risk-adapted treatment of acute promyelocytic leukemia with all-trans-retinoic acid and anthracycline monochemotherapy: a multicenter study by the PETHEMA … MA Sanz, G Martín, M González, A León, C Rayón, C Rivas, D Colomer, ... Blood 103 (4), 1237-1243, 2004 | 609 | 2004 |
| Landscape of somatic mutations and clonal evolution in mantle cell lymphoma S Beà, R Valdés-Mas, A Navarro, I Salaverria, D Martín-Garcia, P Jares, ... Proceedings of the National Academy of Sciences 110 (45), 18250-18255, 2013 | 598 | 2013 |
| Deregulated expression of cytokine receptor gene, CRLF2, is involved in lymphoid transformation in B-cell precursor acute lymphoblastic leukemia LJ Russell, M Capasso, I Vater, T Akasaka, OA Bernard, MJ Calasanz, ... Blood, The Journal of the American Society of Hematology 114 (13), 2688-2698, 2009 | 582 | 2009 |
| A Modified AIDA Protocol With Anthracycline-Based Consolidation Results in High Antileukemic Efficacy and Reduced Toxicity in Newly Diagnosed PML/RAR-Positive Acute … MA Sanz, G Martı́n, C Rayón, J Esteve, M González, J Dı́az-Mediavilla, ... Blood, The Journal of the American Society of Hematology 94 (9), 3015-3021, 1999 | 541 | 1999 |
| Incidence, characterization and prognostic significance of chromosomal abnormalities in 640 patients with primary myelodysplastic syndromes Solé, Espinet, Sanz, Cervera, Calasanz, Luño, Prieto, Granada, ... British journal of haematology 108 (2), 346-356, 2000 | 387 | 2000 |
| Epigenetic Silencing of the Tumor Suppressor MicroRNA Hsa-miR-124a Regulates CDK6 Expression and Confers a Poor Prognosis in Acute Lymphoblastic … X Agirre, A Vilas-Zornoza, A Jiménez-Velasco, JI Martin-Subero, ... Cancer research 69 (10), 4443-4453, 2009 | 352 | 2009 |
| Frequent mutation of the polycomb-associated gene ASXL1 in the myelodysplastic syndromes and in acute myeloid leukemia J Boultwood, J Perry, A Pellagatti, M Fernandez-Mercado, ... Leukemia 24 (5), 1062-1065, 2010 | 337 | 2010 |
| Cytogenetic risk stratification in chronic myelomonocytic leukemia E Such, J Cervera, D Costa, F Solé, T Vallespí, E Luño, R Collado, ... Haematologica 96 (3), 375, 2011 | 301 | 2011 |
| Recurrent involvement of the REL and BCL11Aloci in classical Hodgkin lymphoma JI Martın-Subero, S Gesk, L Harder, T Sonoki, PW Tucker, ... Blood, The Journal of the American Society of Hematology 99 (4), 1474-1477, 2002 | 301 | 2002 |
| Identification of novel cytogenetic markers with prognostic significance in a series of 968 patients with primary myelodysplastic syndromes F Sole, E Luno, C Sanzo, B Espinet, GF Sanz, J Cervera, MJ Calasanz, ... Haematologica 90 (9), 1168-1178, 2005 | 294 | 2005 |
| Molecular Subsets of Mantle Cell Lymphoma Defined by the IGHV Mutational Status and SOX11 Expression Have Distinct Biologic and Clinical Features A Navarro, G Clot, C Royo, P Jares, A Hadzidimitriou, A Agathangelidis, ... Cancer research 72 (20), 5307-5316, 2012 | 284 | 2012 |
| Promoter hypermethylation of cancer-related genes: a strong independent prognostic factor in acute lymphoblastic leukemia J Roman-Gomez, A Jimenez-Velasco, JA Castillejo, X Agirre, M Barrios, ... Blood 104 (8), 2492-2498, 2004 | 276 | 2004 |
| Down-Regulation of hsa-miR-10a in Chronic Myeloid Leukemia CD34+ Cells Increases USF2-Mediated Cell Growth X Agirre, A Jiménez-Velasco, E San José-Enériz, L Garate, E Bandrés, ... Molecular cancer research 6 (12), 1830-1840, 2008 | 272 | 2008 |
| Epigenetic regulation of Wnt-signaling pathway in acute lymphoblastic leukemia J Román-Gómez, L Cordeu, X Agirre, A Jiménez-Velasco, ... Blood 109 (8), 3462-3469, 2007 | 238 | 2007 |
| Cytogenetic complexity in chronic lymphocytic leukemia: definitions, associations, and clinical impact P Baliakas, S Jeromin, M Iskas, A Puiggros, K Plevova, F Nguyen-Khac, ... Blood, The Journal of the American Society of Hematology 133 (11), 1205-1216, 2019 | 235 | 2019 |
| Five members of the CEBP transcription factor family are targeted by recurrent IGH translocations in B-cell precursor acute lymphoblastic leukemia (BCP-ALL) T Akasaka, T Balasas, LJ Russell, K Sugimoto, A Majid, R Walewska, ... Blood 109 (8), 3451-3461, 2007 | 233 | 2007 |
| Cytogenetic aberrations and their prognostic value in a series of 330 splenic marginal zone B-cell lymphomas: a multicenter study of the Splenic B-Cell Lymphoma Group M Salido, C Baró, D Oscier, K Stamatopoulos, J Dierlamm, E Matutes, ... Blood, The Journal of the American Society of Hematology 116 (9), 1479-1488, 2010 | 228 | 2010 |
| Cytogenetic analysis of 280 patients with multiple myeloma and related disorders: primary breakpoints and clinical correlations MJ Calasanz, JC Cigudosa, MD Odero, C Ferreira, MT Ardanaz, A Fraile, ... Genes, Chromosomes and Cancer 18 (2), 84-93, 1997 | 219 | 1997 |
| Measurable residual disease by next-generation flow cytometry in multiple myeloma B Paiva, N Puig, MT Cedena, L Rosiñol, L Cordón, MB Vidriales, L Burgos, ... Journal of Clinical Oncology 38 (8), 784-792, 2020 | 215 | 2020 |
Felipe ProsperClinica Universidad de NavarraDirección de correo verificada de unav.es
